Ocular growth and nicotinic antagonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/135 (2006.01) A61K 31/13 (2006.01) A61K 31/44 (2006.01) A61K 31/445 (2006.01) A61K 31/4747 (2006.01) A61P 27/10 (2006.01)

Patent

CA 2400803

The invention relates to a method comprising the step of ocular administration of therapeutically effective amounts of a nicotinic antagonist to control postnatal ocular growth or inhibit the development of myopia.

Cette invention concerne une méthode consistant à administrer au plan oculaire des doses efficaces au plan thérapeutique d'un antagoniste nicotinique propre à réguler la croissance oculaire postnatale et à empêcher l'apparition d'une myopie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ocular growth and nicotinic antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ocular growth and nicotinic antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ocular growth and nicotinic antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1570287

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.